On 2 May 2025, the Scientific Committee on Consumer Safety (SCCS) published its final opinion on children’s exposure assessment for methyl salicylate. For more information about the mandate for this review, […]
The ICH Q1 draft Guideline on “Stability Testing of Drug Substances and Drug Products” has reached Step 2b of the ICH Process on 11 April 2025 and entered the public consultation period. […]
The Notice to Stakeholders concerning review of the Cosmetic Ingredient Hotlist has now been posted. The purpose of this notice is to inform stakeholders of substances that Health Canada […]
PRODUCT LICENSING: There are approximately 3712 files in Class III (3610 in April) (this includes new and post-licensing files that are in queue and working), of those approximately 605 […]
We are writing to share an important update regarding the format of our upcoming Regulatory Workshops. Based on the valuable feedback we received from our post-workshop surveys, we have […]
Below is the new edition of COSMED REGULATORY BRIEFING, providing key updates on global regulatory developments. This issue explains the EU Packaging and Packaging Waste Regulation (PPWR) and its […]
The Scientific Committee on Consumer Safety (SCCS) evaluated the safety of Benzophenone-2 (BP-2) and Benzophenone-5 (BP-5) in cosmetics, with a particular focus on their potential to be endocrine disruptors. […]
On March 5, 2025, Cosmetics Alliance notified members that the Natural and Non-prescription Health Products Directorate (NNHPD) was changing the order in which they will review Class III NHPs […]
The Natural and Non-prescription Health Products Directorate (NNHPD) will published the following 5 monographs on April 25, 2025. CA’s running list of monograph updates may be found here. Monographs not […]
PRODUCT LICENSING: No change since the last updated here. SITE LICENSING: No change since the last updated here.
